Who we are

Headquartered in Espoo, Finland, Mobidiag is a biotechnology company specializing in developing and marketing novel, innovative solutions for molecular diagnostics of infectious diseases. Mobidiag has a subsidiary in Paris, France.

Our solution

Mobidiag develops cutting-edge diagnostic platforms and test kits. Our mission is to address the unmet need for high information-density, affordable molecular diagnostic tools to enable the rapid treatment and triage of patients at the point of impact.

Amplidiag®
Mobidiag’s Amplidiag product line encompasses multiplex diagnostic tests for gastrointestinal infections. The products utilize well-established multiplex real-time PCR technology for optimal performance, suitability to high-volume screening use and cost-effectiveness in large laboratory settings. Amplidiag Easy makes your stool testing workflow fast and easy – from primary sample to final result. All products come with Amplidiag Analyzer – an intuitive software for automated result analysis and reporting.

Novodiag®
The entirely new Novodiag platform is a fully integrated and automated system, which enables fast, easy to use and highly multiplexed on-demand molecular testing for any throughput needs. It combines advanced features, ease of use, and affordability unmatched by currently available products.

Prove-it®
Prove-it products are rapid, DNA-based high-multiplex assays utilizing PCR and microarray technologies. Results are provided in an unambiguous and user-friendly way with Prove-it Advisor software.

Benefits

Contact information

Tuomas Tenkanen

tuomas.tenkanen(a)mobidiag.com

+358 5055 34980

mobidiag.com/

Related posts